Shanghai Junshi Biosciences Co., Ltd.

SEHK:1877 Stock Report

Market Cap: HK$22.7b

Shanghai Junshi Biosciences Balance Sheet Health

Financial Health criteria checks 5/6

Shanghai Junshi Biosciences has a total shareholder equity of CN¥7.3B and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 23.7%. Its total assets and total liabilities are CN¥11.3B and CN¥4.0B respectively.

Key information

23.7%

Debt to equity ratio

CN¥1.74b

Debt

Interest coverage ration/a
CashCN¥3.79b
EquityCN¥7.32b
Total liabilitiesCN¥4.02b
Total assetsCN¥11.34b

Recent financial health updates

Recent updates

Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?

Mar 22
Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?

Risks Still Elevated At These Prices As Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Dive 29%

Jan 26
Risks Still Elevated At These Prices As Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Dive 29%

Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

Dec 17
Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

Is Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Trading At A 38% Discount?

Nov 20
Is Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Trading At A 38% Discount?

Health Check: How Prudently Does Shanghai Junshi Biosciences (HKG:1877) Use Debt?

Sep 05
Health Check: How Prudently Does Shanghai Junshi Biosciences (HKG:1877) Use Debt?

Revenues Not Telling The Story For Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

May 22
Revenues Not Telling The Story For Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Could Be 35% Below Their Intrinsic Value Estimate

May 01
Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Could Be 35% Below Their Intrinsic Value Estimate

A Look At The Intrinsic Value Of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Jan 16
A Look At The Intrinsic Value Of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Some Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Analysts Just Made A Major Cut To Next Year's Estimates

Nov 03
Some Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Analysts Just Made A Major Cut To Next Year's Estimates

Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

Oct 12
Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?

A Look At The Fair Value Of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Jul 05
A Look At The Fair Value Of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

Financial Position Analysis

Short Term Liabilities: 1877's short term assets (CN¥5.6B) exceed its short term liabilities (CN¥2.4B).

Long Term Liabilities: 1877's short term assets (CN¥5.6B) exceed its long term liabilities (CN¥1.6B).


Debt to Equity History and Analysis

Debt Level: 1877 has more cash than its total debt.

Reducing Debt: 1877's debt to equity ratio has increased from 17.2% to 23.7% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 1877 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 1877 has sufficient cash runway for 2.7 years if free cash flow continues to reduce at historical rates of 17.8% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.